Have a personal or library account? Click to login
Almanac 2013: novel non-coronary cardiac interventions Cover

Almanac 2013: novel non-coronary cardiac interventions

Seminars in Cardiovascular Medicine
Volume 19 (2013): Issue 2 (December 2013)
By: Pascal Meier,  Olaf Franzen and  Alexandra J. Lansky  
Open Access
|Jan 2014

References

  1. [1] Meier P, Timmis A. Almanac 2012: interventional cardiology.10.5152/akd.2013.049
    Search in Google Scholar
  2. Anadolu Kardiyol Derg 2012;13:91-101.
    Search in Google Scholar
  3. [2] Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6.10.1161/01.CIR.0000140263.20897.42
    Search in Google Scholar
  4. [3] European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al.
    Search in Google Scholar
  5. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
    Search in Google Scholar
  6. [4] Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008;6:1500-6.10.1111/j.1538-7836.2008.03059.x
    Search in Google Scholar
  7. [5] Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003;42:1253-8.10.1016/S0735-1097(03)00954-9
    Search in Google Scholar
  8. [6] MEMBERS WC, Bonow RO, Carabello BA, et al. 2008
    Search in Google Scholar
  9. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998
    Search in Google Scholar
  10. Guidelines for the Management of PatientsWith Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
    Search in Google Scholar
  11. Circulation 2008;118:e523-661.
    Search in Google Scholar
  12. [7] Khattab AA, Meier B. Transcatheter left atrial appendage exclusion, gold or fool’s gold? Eur Heart J Suppl 2010;12:E35-40.10.1093/eurheartj/suq008
    Search in Google Scholar
  13. [8] Sousa JE, Costa MA, Tuzcu EM, et al. New frontiers in interventional cardiology. Circulation 2005;111:671-81.10.1161/01.CIR.0000153802.70682.22
    Search in Google Scholar
  14. [9] Munkholm-Larsen S, Cao C, Yan TD, et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart 2012;98:900-7.10.1136/heartjnl-2011-301256
    Search in Google Scholar
  15. [10] Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.10.1016/S0140-6736(09)61343-X
    Search in Google Scholar
  16. [11] Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013;127:720-9.10.1161/CIRCULATIONAHA.112.11438923325525
    Search in Google Scholar
  17. [12] Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123:417-24.10.1161/CIRCULATIONAHA.110.97644921242484
    Search in Google Scholar
  18. [13] Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol 2013;111:869-73.10.1016/j.amjcard.2012.11.06123312129
    Search in Google Scholar
  19. [14] Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012;59:923-9.10.1016/j.jacc.2011.11.02822381428
    Search in Google Scholar
  20. [15] Bass JL. Transcatheter occlusion of the left atrial appendage - experimental testing of a new Amplatzer device.
    Search in Google Scholar
  21. Catheter Cardiovasc Interv 2010;76:181-5.
    Search in Google Scholar
  22. [16] Fox BD, Kahn SR, Langleben D, et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ 2012;345:e7498.10.1136/bmj.e7498349655323150473
    Search in Google Scholar
  23. [17] Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.
    Search in Google Scholar
  24. Eur Heart J 2012;33:2719-47.
    Search in Google Scholar
  25. [18] Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012;98:iv7-13.10.1136/heartjnl-2012-30239523143128
    Search in Google Scholar
  26. [19] Alfieri O, Denti P. Alfieri stitch and its impact on mitral clip. Eur J Cardiothorac Surg 2011;39:807-8.10.1016/j.ejcts.2011.01.01721353584
    Search in Google Scholar
  27. [20] Delgado V, Kapadia S, Marsan NA, et al. Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart 2011;97:1704-14.10.1136/hrt.2011.22778521949284
    Search in Google Scholar
  28. [21] Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005;46:2134-40.10.1016/j.jacc.2005.07.06516325053
    Search in Google Scholar
  29. [22] Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.10.1056/NEJMoa100935521463154
    Search in Google Scholar
  30. [23] Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J Am Coll Cardiol 2012;59:130-9.10.1016/j.jacc.2011.08.06722222076
    Search in Google Scholar
  31. [24] Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.10.1016/j.jacc.2009.03.07719679246
    Search in Google Scholar
  32. [25] Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.10.1093/eurheartj/ehq051
    Search in Google Scholar
  33. [26] Sürder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry.
    Search in Google Scholar
  34. Heart 2013;99:1034-40.
    Search in Google Scholar
  35. [27] Kar S, Rinaldi M, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: demographics and procedural outcomes. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
    Search in Google Scholar
  36. [28] Rinaldi MJ, Kar S, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: analysis of a 6 month patient cohort. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
    Search in Google Scholar
  37. [29] Sarkar K, Ussia GP, Cammalleri V, et al. Quality of life of high risk patients following percutaneous mitral valve repair with the MitraClip system. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.
    Search in Google Scholar
  38. [30] Gaemperli O, Moccetti M, Surder D, et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-32.10.1136/heartjnl-2011-300705
    Search in Google Scholar
  39. [31] Samad Z, Kaul P, Shaw LK, et al. Impact of early surgery on survival of patients with severe mitral regurgitation.
    Search in Google Scholar
  40. Heart 2011;97:221-4.10.1136/hrt.2010.202432
    Search in Google Scholar
  41. [32] Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.10.1016/S0140-6736(06)69208-8
    Search in Google Scholar
  42. [33] Rosenhek R. Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Heart 2011;97:2007-17.10.1136/heartjnl-2011-30139622116890
    Search in Google Scholar
  43. [34] Sinning J-M, Werner N, Nickenig G, et al. Transcatheter aortic valve implantation: the evidence. Heart 2012;98:iv65-72.10.1136/heartjnl-2012-30239323143127
    Search in Google Scholar
  44. [35] Agnihotri A. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: executive summary. J Thorac Cardiovasc Surg 2012;144:534-7.10.1016/j.jtcvs.2012.07.02122898502
    Search in Google Scholar
  45. [36] Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6. 10.1136/heartjnl-2011-30044422076021
    Search in Google Scholar
DOI: https://doi.org/10.2478/semcard-2013-0008 | Journal eISSN: 1822-7767
Journal RSS Feed
Language: English
Page range: 60 - 71
Published on: Jan 29, 2014
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology

© 2014 Pascal Meier, Olaf Franzen, Alexandra J. Lansky, published by Sciendo
This work is licensed under the Creative Commons License.

Previous articleVolume 19 (2013): Issue 2 (December 2013)Next article